CSIMarket
 


Rebus Holdings Inc   (NSPX)
Other Ticker:  
 
 

NSPX's EPS Net Growth by Quarter and Year

Rebus Holdings Inc 's EPS Net results by quarter and year




NSPX EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.00 0.16
III Quarter September - 0.01 -0.01 -0.23
II Quarter June 0.00 -0.04 0.03 -0.36
I Quarter March -0.01 0.00 -0.05 0.07
FY   -0.01 -0.03 -0.03 -0.36



NSPX EPS Net second quarter 2023 Y/Y Growth Comment
Rebus Holdings Inc in the second quarter 2023 recorded EPS net loss of $ 0.00 .

According to the results reported in the second quarter 2023, Rebus Holdings Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Rebus Holdings Inc ' s EPS Net no change of % ranks overall at the positon no. in the second quarter 2023.




NSPX EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - 133.33 %
FY   - - - -

Financial Statements
Rebus Holdings Inc 's second quarter 2023 EPS Net $ 0.00 NSPX's Income Statement
Rebus Holdings Inc 's second quarter 2022 EPS Net $ -0.04 Quarterly NSPX's Income Statement
New: More NSPX's historic EPS Net Growth >>


NSPX EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Rebus Holdings Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NSPX's II. Quarter Q/Q EPS Net Comment
Although Rebus Holdings Inc in the II. Quarter 2023 admitted EPS net loss of $ 0.00 , some analyst point out, that current results show improvement in contrast to the -0.01 in the first quarter.

Within Major Pharmaceutical Preparations industry Rebus Holdings Inc achieved highest sequential EPS Net growth. While Rebus Holdings Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NSPX's II. Quarter Q/Q EPS Net Comment
Despite the fact, that Rebus Holdings Inc in the II. Quarter 2023 revealed EPS net loss of $ 0.00 , management point out, that this point to recovery relative to the -0.01 in the first quarter.

Within Major Pharmaceutical Preparations industry Rebus Holdings Inc achieved highest sequential EPS Net growth. While Rebus Holdings Inc 's EPS Net growth quarter on quarter, overall rank is .


Rebus Holdings Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative EPS Net 12 Months Ending $ 0.00 $ -0.04 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
In the Jun 30 2023 period, Rebus Holdings Inc 's cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Rebus Holdings Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
In the Jun 30 2023 period, Rebus Holdings Inc 's cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Rebus Holdings Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
NSPX's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for NSPX's Competitors
EPS Net Growth for Rebus Holdings Inc 's Suppliers
EPS Net Growth for NSPX's Customers

You may also want to know
NSPX's Annual Growth Rates NSPX's Profitability Ratios NSPX's Asset Turnover Ratio NSPX's Dividend Growth
NSPX's Roe NSPX's Valuation Ratios NSPX's Financial Strength Ratios NSPX's Dividend Payout Ratio
NSPX's Roa NSPX's Inventory Turnover Ratio NSPX's Growth Rates NSPX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2023
Prestige Consumer Healthcare Inc -2.75%$ -2.752 
Radnet Inc -7.69%$ -7.692 
Gilead Sciences Inc -8.79%$ -8.791 
Acadia Healthcare Company Inc -10.23%$ -10.227 
National Research Corporation-12.12%$ -12.121 
Viatris Inc -15.38%$ -15.385 
West Pharmaceutical Services Inc -16.94%$ -16.935 
Davita Inc -16.96%$ -16.957 
Assertio Holdings inc -18.75%$ -18.750 
Chemed Corporation-20.23%$ -20.227 
Dariohealth Corp -21.62%$ -21.622 
Edwards Lifesciences Corporation-23.08%$ -23.077 
U S Physical Therapy Inc-26.44%$ -26.437 
Sotera Health Company-27.27%$ -27.273 
Thorne Healthtech Inc -27.27%$ -27.273 
Atrion Corporation-28.27%$ -28.269 
Royalty Pharma Plc-28.57%$ -28.571 
Abbott Laboratories-31.58%$ -31.579 
Orgenesis Inc -31.82%$ -31.818 
Carlisle Companies Incorporated-33.86%$ -33.857 
Vanda Pharmaceuticals Inc -40.00%$ -40.000 
Organogenesis Holdings Inc -42.86%$ -42.857 
Biogen Inc -43.78%$ -43.785 
Laboratory Corporation Of America Holdings-45.22%$ -45.220 
Lftd Partners Inc -50.00%$ -50.000 
Renovaro Inc -51.52%$ -51.515 
Biomx Inc -52.00%$ -52.000 
Repligen Corp-60.23%$ -60.227 
Embecta Corp -75.70%$ -75.701 
Puma Biotechnology Inc -76.19%$ -76.190 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com